4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 8-24, 2024
Virtual
American Conference Institute (ACI)
Finnegan partner David Weingarten will present “The Orange Books: Listings, De- Listings and Other Matters of Interest” at the American Conference Institute’s (ACI) 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA conference. The program will provide a deep dive discussion of Hatch-Waxman and the BPCIA litigation and regulation, as well as other IP basics relative to biologics. For more information, or to register, please see the ACI’s website.
Tags
Biologics Price Competition and Innovation Act (BPCIA), Orange Book, Food and Drug Administration (FDA), FDA Guidance
